Skip to content
Search

Latest Stories

Submit Guest Post

Bangalore vocalist Radhika Balakrishnan appointed to Birmingham chair

She will be a visiting professor for the Chair of Indian Music at the Royal Birmingham Conservatoire for one semester

Bangalore vocalist Radhika Balakrishnan appointed to Birmingham chair

A Bangalore-based Carnatic classical vocalist has been appointed a visiting professor for the Chair of Indian Music at the Royal Birmingham Conservatoire.

Radhika Balakrishnan will be in the role for one semester and she is scheduled to participate in a public seminar on the Nadaswaram - a wind instrument popular in south India - at the conservatoire on March 21.

The Chair of Indian Music has been set up by the Indian Council for Cultural Relations (ICCR) at Birmingham City University/Royal Birmingham Conservatoire to promote cultural exchanges.

Radhika who graduated from the University of Mysore in south India in 2007, has been performing since 2006.

She is also an associate professor and content creator in the Carnatic vocal department at Shankar Mahadevan Academy.

In a statement reported by the Times of India, Radhika thanked the ICCR for choosing her to “introduce Indian classical music and culture on such a prestigious global platform”.

The vocalist hoped to help future western musicians build “a deeper appreciation” for India’s classical music tradition.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

cervical -cancer-hpv-vaccine

HPV is the most common sexually transmitted infection

Photo for representation: iStock

HPV vaccine reduces cervical cancer deaths to near zero, study finds

Highlights

  • No women aged 20–24 died from cervical cancer in England between 2020 and 2024
  • HPV vaccination is estimated to have prevented nearly 200 deaths among young women
  • Study provides first direct evidence linking HPV vaccination to reduced cervical cancer mortality
  • Vaccine introduced for girls in 2008 in the UK
  • Researchers say higher vaccination uptake is needed to protect future gains

THE HPV vaccine for cervical cancer has reduced the risk of dying from the disease before the age of 30 in England to almost zero, the first study of its kind showed on Thursday (18).

Keep ReadingShow less